Kazia Therapeutics
KZIA
9 hedge funds and large institutions have $89.5K invested in Kazia Therapeutics in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 9 → 9 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
23% less capital invested
Capital invested by funds: $116K → $89.5K (-$26K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12.3K |
| 2 |
VF
Virtu Financial
New York
|
+$11.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$6.94K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$4.45K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$1.62K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HSBC Holdings
London,
United Kingdom
|
-$20.1K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$5.81K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$5.71K |
| 4 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$3.51K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Morgan Stanley
New York
| $46K | +$966 | +65 | +2% |
|
|
2
BNP Paribas Financial Markets
Paris,
France
| $14.5K | +$4.45K | +299 | +31% |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $9.46K | +$12.3K | +830 | New |
|
|
VF
4
Virtu Financial
New York
| $9K | +$11.7K | +786 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $5.34K | +$6.94K | +467 | New |
|
|
6
RhumbLine Advisers
Boston,
Massachusetts
| $4.01K | +$1.62K | +109 | +45% |
|
7
Citadel Advisors
Miami,
Florida
| $1.04K | +$1.35K | +91 | New |
|
8
Wells Fargo
San Francisco,
California
| $114 | – | – | – |
|
|
AF
9
Allworth Financial
Folsom,
California
| $46 | – | – | – |
|
|
AF
10
Advisornet Financial
Minnetonka,
Minnesota
| $1 | – | – | – |
|
11
JP Morgan Chase
New York
| $1 | – | – | – |
|
|
12
HSBC Holdings
London,
United Kingdom
| – | -$20.1K | -1,279 | Closed |
|
|
XT
13
XTX Topco
George Town,
Cayman Islands
| – | -$5.81K | -370 | Closed |
|
|
TSS
14
Two Sigma Securities
New York
| – | -$5.71K | -368 | Closed |
|
|
GSC
15
Ground Swell Capital
Folly Beach,
South Carolina
| – | -$3.51K | -223 | Closed |
|
KZIA Hedge Fund Activity: Q2 2024 in Review
9 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q2 2024, worth a combined $89.5K — down 23% from $116K a quarter earlier.
Fund positioning in KZIA was balanced in Q2 2024: 4 funds opened new positions, 4 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $12.3K. The largest seller was HSBC Holdings, exiting entirely with an estimated $20.1K sold.
- 9 institutional investors held Kazia Therapeutics (KZIA) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $89.5K of Kazia Therapeutics stock for Q2 2024, down 23% quarter-over-quarter.
- 4 funds opened new Kazia Therapeutics positions in Q2 2024 and 4 closed out, a net change of 0 holders.
- The largest Kazia Therapeutics buyer in Q2 2024 was Susquehanna International Group, an estimated $12.3K added.
- The largest Kazia Therapeutics seller in Q2 2024 was HSBC Holdings, an estimated $20.1K sold.
Based on aggregated 13F filings for Q2 2024.